HealthDay News — Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals, according to a study published online Aug. 23 in the British ...

A retrospective study explored the impact of preexisting cardiovascular disease on adverse events in patients with hematologic malignancies receiving BTK inhibitors.

A novel CAR T-cell therapy, GCC19CART, has demonstrated activity in patients with heavily pretreated, metastatic colorectal cancer.

No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting.

Scott E. Hadland, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues recommend that acute pain should be treated using a multimodal approach, including appropriate use of ...

HealthDay News — The overall second primary malignancy (SPM) point estimate was 5.8 percent for patients receiving chimeric antigen receptor (CAR) T-cell therapy, according to a study published online ...

Study compared telehealth with in-person meeting as a modality for effective delivery of early palliative care.

Researchers sought to determine whether complete remission with partial hematological recovery is beneficial in patients with AML.

Data suggest that neoadjuvant immune checkpoint inhibitor (ICI) therapy improves outcomes in patients with early-stage triple-negative breast cancer, but adjuvant ICI therapy does not.

Inotuzumab ozogamicin (InO) is an active antibody-drug conjugate that works by delivering the chemotherapeutic payload calicheamicin to cells expressing CD22. Studies demonstrate that InO elicits high ...

Population-based cohort study identifies better treatment objectives for women with advanced-stage ovarian cancer.

The incidence of head and neck cancer increased among patients in the cannabis-related disorder group compared with patients without cannabis-related disorder (0.285% vs 0.091%, respectively).